RS 23597-190 hydrochloride5-HT4 antagonist CAS# 149719-06-2 |
- Perindopril Erbumine
Catalog No.:BCC3586
CAS No.:107133-36-8
- Losartan Potassium (DuP 753)
Catalog No.:BCC1080
CAS No.:124750-99-8
- Candesartan
Catalog No.:BCC2558
CAS No.:139481-59-7
- Telmisattan
Catalog No.:BCC3863
CAS No.:144701-48-4
- Imidapril HCl
Catalog No.:BCC3792
CAS No.:89396-94-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 149719-06-2 | SDF | Download SDF |
PubChem ID | 182592 | Appearance | Powder |
Formula | C16H24Cl2N2O3 | M.Wt | 363.28 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in water | ||
Chemical Name | 3-piperidin-1-ylpropyl 4-amino-5-chloro-2-methoxybenzoate;hydrochloride | ||
SMILES | COC1=CC(=C(C=C1C(=O)OCCCN2CCCCC2)Cl)N.Cl | ||
Standard InChIKey | QLZLBYYNMGQIAR-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C16H23ClN2O3.ClH/c1-21-15-11-14(18)13(17)10-12(15)16(20)22-9-5-8-19-6-3-2-4-7-19;/h10-11H,2-9,18H2,1H3;1H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | A high affinity, selective competitive antagonist at 5-HT4 receptors. |
RS 23597-190 hydrochloride Dilution Calculator
RS 23597-190 hydrochloride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.7527 mL | 13.7635 mL | 27.527 mL | 55.054 mL | 68.8174 mL |
5 mM | 0.5505 mL | 2.7527 mL | 5.5054 mL | 11.0108 mL | 13.7635 mL |
10 mM | 0.2753 mL | 1.3763 mL | 2.7527 mL | 5.5054 mL | 6.8817 mL |
50 mM | 0.0551 mL | 0.2753 mL | 0.5505 mL | 1.1011 mL | 1.3763 mL |
100 mM | 0.0275 mL | 0.1376 mL | 0.2753 mL | 0.5505 mL | 0.6882 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- AHU-377(Sacubitril)
Catalog No.:BCC4088
CAS No.:149709-62-6
- Stachybotrolide
Catalog No.:BCN6968
CAS No.:149691-31-6
- Pefloxacin Mesylate Dihydrate
Catalog No.:BCC5089
CAS No.:149676-40-4
- Isomorellinol
Catalog No.:BCN3075
CAS No.:149655-53-8
- Isogambogic acid
Catalog No.:BCN3078
CAS No.:149655-52-7
- Chrysosplenol D
Catalog No.:BCN1666
CAS No.:14965-20-9
- Nafadotride
Catalog No.:BCC7025
CAS No.:149649-22-9
- Vorinostat (SAHA, MK0683)
Catalog No.:BCC2145
CAS No.:149647-78-9
- MOG (35-55)
Catalog No.:BCC3670
CAS No.:149635-73-4
- Impentamine dihydrobromide
Catalog No.:BCC7197
CAS No.:149629-70-9
- Stachybotramide
Catalog No.:BCN6969
CAS No.:149598-71-0
- Marmin
Catalog No.:BCN1665
CAS No.:14957-38-1
- H-Arg-NH2.2HCl
Catalog No.:BCC2859
CAS No.:14975-30-5
- Tereticornate A
Catalog No.:BCN1667
CAS No.:149751-81-5
- Clemastine Fumarate
Catalog No.:BCC4528
CAS No.:14976-57-9
- Delaminomycin A
Catalog No.:BCN1833
CAS No.:149779-38-4
- Homoeriodictyol 7-O-glucoside
Catalog No.:BCN7740
CAS No.:14982-11-7
- Saquinavir mesylate
Catalog No.:BCC1922
CAS No.:149845-06-7
- 2-MPMDQ
Catalog No.:BCC6741
CAS No.:149847-77-8
- AAL Toxin TB1
Catalog No.:BCN1734
CAS No.:149849-90-1
- AAL Toxin TB2
Catalog No.:BCN1739
CAS No.:149849-91-2
- Azimilide Dihydrochloride
Catalog No.:BCC5536
CAS No.:149888-94-8
- H-Glu(OMe)-OH
Catalog No.:BCC2931
CAS No.:1499-55-4
- Azimilide
Catalog No.:BCC5535
CAS No.:149908-53-2
Central 5-HT4 receptors.[Pubmed:8578609]
Trends Pharmacol Sci. 1995 Nov;16(11):391-8.
Activation of the 5-HT4 receptor mediates widespread effects in central and peripheral nervous systems. Recent developments, such as the identification of novel, selective agonists and antagonists, as well the cloning of the receptor, have provided insights into the physiological role of the receptor. In this article, Richard Eglen and colleagues assess the emerging evidence relating to the function of the 5-HT4 receptor in the brain. The cerebral distribution of the receptor, along with neurochemical and electrophysiological data, suggests a role in cognition. The role of the receptor in modulation of dopamine transmission and anxiolysis is also addressed.
RS 23597-190: a potent and selective 5-HT4 receptor antagonist.[Pubmed:8220871]
Br J Pharmacol. 1993 Sep;110(1):119-26.
1. The pharmacological properties of RS 23597-190 (3-(piperdine-1-yl)-propyl-4-amino-5-chloro-2-methoxy benzoate hydrochloride) have been studied in vitro and in vivo. 2. RS 23597-190 competitively antagonized 5-HT4 receptor-mediated relaxations of rat, carbachol precontracted oesophageal muscularis mucosae, (pA2 = 7.8 +/- 0.1; Schild slope = 1.2 +/- 0.2). Affinity estimates (-log KB) at 5-HT4 receptors using either renzapride or SC-53116 as agonists yielded a -log KB value of 8.0 +/- 0.01. In contrast, RS 23597-190 failed to antagonize contractile responses to 5-HT of guinea-pig ileal 5-HT3 receptors, even at concentrations up to 10 microM. 3. Increases in short-circuit current, induced by 5-HT, were studied in guinea-pig ileal mucosal sheets. Concentration-response curves to 5-HT were biphasic, with the high potency phase to 5-HT inhibited by RS 23597-190 and mimicked by 5-methoxytryptamine. The -log KB value for RS 23597-190 at the high potency phase was 7.3 confirming that 5-HT4 receptors mediated the high potency phase. 4. In rat isolated vagus nerve, 5-HT elicited a slow, maintained depolarization at low concentrations and a rapid, transient depolarization at higher concentrations. The high potency, slow depolarizing phase to 5-HT was abolished selectively in the presence of 1 microM RS 23597-190 and the low potency phase was abolished selectively in the presence of 1 microM ondansetron. These data confirm that 5-HT4 and 5-HT3 receptors mediated slow and fast depolarization responses, respectively. 5. At 5-HT3 binding sites in membranes from NG 108-15 cells, labelled by [3H]-quipazine, RS 23597-190 exhibited an apparent affinity (- log Ki) of 5.7 +/- 0.1. At 5-HT3 receptors in membranes from rat cerebral cortex, labelled by [3H]-RS 42358-197, the apparent affinity (- log Ki) of RS 23597-190 was also 5.7 +/- 0.1. In both studies, Hill coefficients were not significantly different from unity. At 5-HT1A, 5-HT2,muscarinic M1, M2, M3, M4 and dopamine D1 and D2 receptors, RS 23597-190 exhibited low apparent affinities, with all - log Ki values less than 5.5.6. Intravenous infusion of RS 23597-190 in the conscious, restrained rat antagonized the von Bezold Jarisch reflex induced by 2-methyl 5-HT, with an ID50 of 300 microg kg-1 min-1, i.v. In the anaesthetized,bilaterally vagotomized micropig, RS 23597-190 (6 mg kg-1, i.v.) antagonized 5-HT-induced tachycardia with a half-life of 77 (63-99) min. Transient arrhythmic effects were noted after administration of the compound.7. In conclusion, RS 23597-190 acts as a high affinity, selective competitive antagonist at 5-HT4 receptors. Thus, the compound appears to be a useful tool for 5-HT4 receptor identification in vitro. In vivo, the compound is rapidly metabolized in pigs such that 5-HT4 blockade is not maintained. However,in the rat, when given by infusion, RS 23597-190 antagonizes 5-HT3 mediated responses, at doses consistent with a low affinity 5-HT3 receptor. These data suggest that, under appropriate experimental conditions, RS 23597-190 may also be used in vivo to characterize further 5-HT4 receptor function.